The Lancet Neurology in conversation with

187 Episodo

1. William Jagust on amyloid β and cognition

   Publicado: 16/8/2023
2. Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury

   Publicado: 19/7/2023
3. Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases

   Publicado: 21/6/2023
4. Andrew Cole on the complexities underlying epilepsy in people with glioblastoma

   Publicado: 18/5/2023
5. Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation

   Publicado: 13/4/2023
6. Kerstin Hellwig on family planning considerations in MS

   Publicado: 15/3/2023
7. Geraldine Dawson on advances in the prediction of autism during infancy

   Publicado: 16/2/2023
8. Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke

   Publicado: 19/1/2023
9. Beau Ances on amyloid biomarkers in Alzheimer’s

   Publicado: 12/12/2022
10. Axel Petzold on the diagnosis and classification of optic neuritis

    Publicado: 16/11/2022
11. Maeike Zijlmans on using biomarkers to tailor epilepsy surgery

    Publicado: 18/10/2022
12. Jerome Siegel on sleep habits

    Publicado: 14/9/2022
13. Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy

    Publicado: 10/8/2022
14. Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy

    Publicado: 13/7/2022
15. Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies

    Publicado: 15/6/2022
16. Mark Hallett on functional neurological disorder

    Publicado: 13/5/2022
17. Eva Feldman on advances in understanding ALS

    Publicado: 13/4/2022
18. Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's

    Publicado: 6/4/2022
19. John Collinge on a treatment for CJD

    Publicado: 16/3/2022
20. Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2

    Publicado: 22/2/2022